Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Vertosick

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
NPJ Precision Oncology|April 9, 2022
Prostate cancer polygenic risk score and prediction of lethal prostate cancerRobert J Klein, Emily Vertosick, Dan Sjoberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2017
Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trialGary Deng, Sergio Giralt, David J Chung, et al.
The Journal of Urology|February 13, 2019
The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve StudyCarlo Andrea Bravi, Amy Tin, Emily Vertosick, et al.
BMC Medicine|February 12, 2014
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigenAndrew J Vickers, Daniel D Sjoberg, David Ulmert, et al.
European Urology Oncology|August 15, 2019
Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume InstitutionCarlo Andrea Bravi, Emily Vertosick, Amy Tin, et al.
The Journal of Urology|February 13, 2014
Clinical outcomes of local and metastatic testicular sex cord-stromal tumorsJonathan L Silberstein, Wassim M Bazzi, Emily Vertosick, et al.
The Journal of Urology|September 13, 2015
The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell CarcinomaNick W Liu, James D Wren, Emily Vertosick, et al.
European Urology|October 6, 2018
Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer SurvivalWeiqiang Li, Mridu Middha, Mesude Bicak, et al.
The Journal of Urology|January 9, 2024
Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?Jose M Flores, Emily Vertosick, Lawrence C Jenkins, et al.
Minerva Urology and Nephrology|February 22, 2020
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institutionCarlo A Bravi, Giuseppe Rosiello, Giuseppe Fallara, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
NPJ Precision Oncology|April 9, 2022
Prostate cancer polygenic risk score and prediction of lethal prostate cancerRobert J Klein, Emily Vertosick, Dan Sjoberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2017
Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trialGary Deng, Sergio Giralt, David J Chung, et al.
The Journal of Urology|February 13, 2019
The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve StudyCarlo Andrea Bravi, Amy Tin, Emily Vertosick, et al.
BMC Medicine|February 12, 2014
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigenAndrew J Vickers, Daniel D Sjoberg, David Ulmert, et al.
European Urology Oncology|August 15, 2019
Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume InstitutionCarlo Andrea Bravi, Emily Vertosick, Amy Tin, et al.
The Journal of Urology|February 13, 2014
Clinical outcomes of local and metastatic testicular sex cord-stromal tumorsJonathan L Silberstein, Wassim M Bazzi, Emily Vertosick, et al.
The Journal of Urology|September 13, 2015
The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell CarcinomaNick W Liu, James D Wren, Emily Vertosick, et al.
European Urology|October 6, 2018
Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer SurvivalWeiqiang Li, Mridu Middha, Mesude Bicak, et al.
The Journal of Urology|January 9, 2024
Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?Jose M Flores, Emily Vertosick, Lawrence C Jenkins, et al.
Minerva Urology and Nephrology|February 22, 2020
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institutionCarlo A Bravi, Giuseppe Rosiello, Giuseppe Fallara, et al.
Pageof 5